Karachi: BF Biosciences Limited has announced the approval of its annual budget for the fiscal year 2026-27. The board of directors reached this decision during a meeting held on July 13, 2026, at 5:00 PM. This information was disseminated to the TREC Holders of the Exchange following the meeting.

According to information available from the Pakistan Stock Exchange (PSX), BF Biosciences Limited is listed under the designated market category. The announcement was made public on July 14, 2026, marking a significant step for the company as it prepares for the upcoming fiscal year.

The approval of the budget is a crucial development for BF Biosciences Limited, as it sets the financial framework for the company's operations and strategic initiatives in the coming year. The company will now proceed with implementing its financial plans as outlined in the approved budget.